NASDAQ: FEMYFemasys Inc Stock Ownership - Who owns Femasys?
Insider buying vs selling
Have Femasys Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Daniel Scott Currie | Chief Operating Officer | 2025-06-02 | 19,608 | $1.02 | $20.00kBuy |
| Dov Elefant | Chief Financial Officer | 2025-06-02 | 19,608 | $1.02 | $20.00kBuy |
| Charles Larsen | Director | 2025-06-02 | 24,510 | $1.02 | $25.00kSell |
| Kathy Leesepsick | Chief Executive Officer | 2025-06-02 | 34,314 | $1.02 | $35.00kBuy |
FEMY insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when FEMY insiders and whales buy or sell their stock.
FEMY Shareholders
What type of owners hold Femasys Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Edward R. Uzialko | 4.47% | 1,217,406 | $1.01M | Insider |
| Vanguard Group Inc | 3.49% | 951,867 | $787.19k | Institution |
| Kathy Leesepsick | 1.59% | 432,850 | $357.97k | Insider |
| John Dyett | 1.08% | 292,844 | $242.18k | Insider |
| Geode Capital Management LLC | 0.95% | 258,228 | $213.55k | Institution |
| John Q. Adams Jr. | 0.88% | 239,938 | $198.43k | Insider |
| Clear Creek Financial Management LLC | 0.51% | 138,903 | $114.87k | Institution |
| Daniel Scott Currie | 0.40% | 109,240 | $90.34k | Insider |
| Blackrock Inc | 0.36% | 98,748 | $81.66k | Institution |
| Dov Elefant | 0.21% | 58,436 | $48.33k | Insider |
FEMY vs Medical Stocks
Femasys Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.